Amneal Pharmaceuticals, Inc. financial data

Symbol
AMRX on NYSE
Industry
Pharmaceutical Preparations
Location
400 Crossing Boulevard, 3 Rd Floor, Bridgewater, New Jersey
Fiscal year end
December 31
Former names
Atlas Holdings, Inc. (to 4/13/2018)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 175 % +0.5%
Quick Ratio 70.8 % +8.27%
Return On Equity -251 % -60.1%
Return On Assets -4.58 % +34.7%
Operating Margin 6.38 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 309 M shares
Entity Public Float 464 M USD -1.44%
Weighted Average Number of Shares Outstanding, Basic 307 M shares +102%
Weighted Average Number of Shares Outstanding, Diluted 307 M shares +102%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.5 B USD +9.82%
Research and Development Expense 165 M USD -9.37%
Operating Income (Loss) 159 M USD -131%
Nonoperating Income (Expense) -266 M USD -62.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -106 M USD +57%
Income Tax Expense (Benefit) 13.9 M USD +29.2%
Net Income (Loss) Attributable to Parent -164 M USD +39%
Earnings Per Share, Basic -0.73 USD/shares +18.9%
Earnings Per Share, Diluted -0.73 USD/shares +18.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.5 M USD -67.8%
Accounts Receivable, after Allowance for Credit Loss, Current 546 M USD +1.38%
Inventory, Net 571 M USD +7.87%
Assets, Current 1.38 B USD +5.56%
Property, Plant and Equipment, Net 440 M USD -4.93%
Operating Lease, Right-of-Use Asset 43.3 M USD -22.9%
Intangible Assets, Net (Excluding Goodwill) 859 M USD -18.6%
Goodwill 599 M USD -0.1%
Other Assets, Noncurrent 73.7 M USD -14.7%
Assets 3.46 B USD -4.69%
Accounts Payable, Current 175 M USD +28%
Employee-related Liabilities, Current 44.8 M USD +39.5%
Liabilities, Current 834 M USD +18.6%
Other Liabilities, Noncurrent 41.5 M USD +26.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -23.7 M USD -730%
Retained Earnings (Accumulated Deficit) -582 M USD -40.8%
Stockholders' Equity Attributable to Parent -63.7 M USD -122%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -63.6 M USD -147%
Liabilities and Equity 3.46 B USD -4.69%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.41 M USD -103%
Net Cash Provided by (Used in) Financing Activities -23.2 M USD -79.5%
Net Cash Provided by (Used in) Investing Activities -19.8 M USD -68.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -47.5 M USD -141%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51.6 M USD -65.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 64.5 M USD +57.1%
Deferred Tax Assets, Valuation Allowance 566 M USD +30%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 567 M USD +30.3%
Operating Lease, Liability 48.9 M USD -17.4%
Depreciation 66.2 M USD -2.79%
Payments to Acquire Property, Plant, and Equipment 9.2 M USD -5.06%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -197 M USD -50.6%
Lessee, Operating Lease, Liability, to be Paid 61.3 M USD -19.3%
Property, Plant and Equipment, Gross 956 M USD +4.35%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14.5 M USD -12.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 16 M USD +0.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.4 M USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.7 M USD -25%
Deferred Tax Assets, Operating Loss Carryforwards 74.3 M USD -9.71%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 8.45 M USD +26.9%
Preferred Stock, Shares Authorized 2 M shares 0%
Unrecognized Tax Benefits 3.74 M USD +3.29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.74 M USD -25.5%
Operating Lease, Payments 16 M USD -1.12%
Additional Paid in Capital 539 M USD -23.1%
Current Federal Tax Expense (Benefit) 2.47 M USD
Amortization of Intangible Assets 162 M USD -5.98%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 26.8 M USD -15.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%